VANGUARD GROUP INC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 165 filers reported holding ENDOLOGIX INC in Q2 2016. The put-call ratio across all filers is 104.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$3,263,000
-64.2%
4,556,194
-4.5%
0.00%
Q3 2018$9,109,000
-71.0%
4,769,220
-14.2%
0.00%
-100.0%
Q2 2018$31,445,000
+40.7%
5,555,545
+5.2%
0.00%0.0%
Q1 2018$22,344,000
-39.4%
5,282,404
-23.4%
0.00%
-50.0%
Q4 2017$36,872,000
+26.8%
6,892,223
+5.7%
0.00%
+100.0%
Q3 2017$29,087,000
-9.8%
6,521,794
-1.8%
0.00%
-50.0%
Q2 2017$32,262,000
-29.1%
6,638,302
+5.6%
0.00%0.0%
Q1 2017$45,505,000
+33.1%
6,285,069
+5.1%
0.00%0.0%
Q4 2016$34,198,000
-53.8%
5,978,672
+3.5%
0.00%
-50.0%
Q3 2016$73,971,000
+6.5%
5,778,983
+3.7%
0.00%0.0%
Q2 2016$69,468,000
+54.2%
5,575,344
+3.5%
0.00%
+33.3%
Q1 2016$45,044,000
+1.8%
5,388,098
+20.5%
0.00%0.0%
Q4 2015$44,267,000
-89.1%
4,471,383
-74.4%
0.00%
-80.0%
Q3 2015$404,618,000
+521.1%
17,451,278
+310.9%
0.02%
+275.0%
Q2 2015$65,144,000
-6.6%
4,246,720
+3.9%
0.00%
-20.0%
Q1 2015$69,760,000
+17.7%
4,086,695
+5.4%
0.01%
+25.0%
Q4 2014$59,293,000
+47.0%
3,877,844
+1.9%
0.00%
+33.3%
Q3 2014$40,323,000
-27.9%
3,804,056
+3.4%
0.00%
-25.0%
Q2 2014$55,946,000
+17.3%
3,678,180
-0.7%
0.00%0.0%
Q1 2014$47,694,000
-22.9%
3,705,893
+4.4%
0.00%
-20.0%
Q4 2013$61,879,000
+13.9%
3,548,119
+5.3%
0.01%0.0%
Q3 2013$54,335,000
+27.3%
3,368,580
+4.8%
0.01%
+25.0%
Q2 2013$42,676,0003,213,5060.00%
Other shareholders
ENDOLOGIX INC shareholders Q2 2016
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,000,000$68,280,0009.00%
Essex Woodlands Management, Inc. 1,257,468$26,843,0005.32%
First Light Asset Management, LLC 277,264$4,733,0002.42%
Lisanti Capital Growth, LLC 175,060$2,988,0001.70%
ArrowMark Colorado Holdings LLC 3,150,275$53,775,0001.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,351$40,103,0001.30%
Rail-Splitter Capital Management, LLC 186,076$3,176,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,405,0000.81%
Perceptive Advisors 565,000$9,645,0000.75%
PALISADE CAPITAL MANAGEMENT, LP 1,629,329$27,813,0000.70%
View complete list of ENDOLOGIX INC shareholders